hVIVO plc 2015 Annual Report and Financial Statements (6990W)

TIDMHVO

RNS Number : 6990W

hVIVO plc

28 April 2016

For immediate release 2.00pm: 28 April 2016

HVIVO PLC

("hVIVO" or the "Company")

2015 Annual Report and Financial Statements

hVIVO plc (AIM: HVO), the pioneer of human models of disease, is pleased to announce that its Annual Report and Financial Statements for the year ended 31 December 2015 is being posted to shareholders today. It will be available on the Company's website (http://hvivo.com/investors/financial-reports/) from 4.30 pm today.

For further information please contact:

hVIVO plc [phone]

Kym Denny (Chief Executive Officer)

Graham Yeatman (Chief Financial & Business Officer)

Media Enquiries [phone] / [phone]

Colin Paterson (Director of Marketing, Communication and Public Relations)

Numis Securities Limited [phone]

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black / Michael Burke (Corporate Broking)

Notes to Editors:

hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, RSV, asthma and common cold. hVIVO has commercialised four disease models, successfully enrolled over 2,000 subjects and conducted over 40 product validation studies for a wide range of industry, government and academic clients and collaborators.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSAKFDKNBKDNQB

(END) Dow Jones Newswires

April 28, 2016 09:05 ET (13:05 GMT)